REDDSTAR: Repair of Diabetic Damage by Stromal Cell Administration

$image_alt.data

Currently, there are few therapeutic options to control initiation and progression of vascular complications of diabetes.

Millions of patients with diabetes mellitus in the EU are using prescription drugs to control their blood glucose levels. At present, there are few therapeutic options available to control initiation and progression of diabetic complications and they continue to present challenging disease management issues for clinicians.

Basic information

Country: Denmark, Germany, Ireland, Netherlands, Portugal

Coordinator: REDDSTAR, http://www.reddstar.eu/

Programme: FP7

Project Acronym:

Target groups: general public

Topic: Biomedicine, Medical sciences

Start year: 2012

End year: 2015

Url: http://www.reddstar.eu/

Contact person: Danielle Nicholson, danielle.nicholson (at) orbsentherapeutics.com

Poor control of blood glucose levels leads to a number of diabetic complications, including: nephropathy, retinopathy, cardiomyopathy, neuropathy, impaired bone repair and wound ulceration. REDDSTAR will comprehensively examine whether Stromal Stem Cells can safely control glycaemia and alleviate damage caused by six diabetic complications.

Fact sheets to educate a lay audience on diabetes complications and cell biology are downloadable. We have organised and managed several public meetings, and linked with relevant EU projects.

 

If you know of European or national project in STEM education, please let us know. 

Submit project

 


Read more on what Scientix offers to science education projects


For project managers:

connect with Scientix!


For project managers:

Request support for your project from Scientix Teacher Ambassadors!